GlassScriptPhysician profile
Elie Mansour
NPI 1356314280
$53,805.93
in general payments reported to CMS, 2019-2025
47 companies · $31K in 2025
The $31K reported for 2025 was more than what 96% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,319 · 2020: $893 · 2021: $2,259 · 2022: $3,214 · 2023: $3,610 · 2024: $11K · 2025: $31K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $33K · Food and Beverage: $9,419 · Consulting Fee: $1,075 · Travel and Lodging: $1,046 · Education: $54.96 · Gift: $40.59.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $33,485.00 |
| Food and Beverage | $9,418.74 |
| Consulting Fee | $1,075.00 |
| Travel and Lodging | $1,045.91 |
| Education | $54.96 |
| Gift | $40.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $36,418.05 | 2020-2025 | Acthar |
| Astrazeneca Pharmaceuticals LP | $3,781.25 | 2019-2025 | Fasenra, Breztri, Tezspire |
| Glaxosmithkline, LLC. | $2,523.75 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,151.49 | 2019-2025 | Ofev, Jascayd, Jardiance |
| Actelion Pharmaceuticals US, INC. | $887.27 | 2019-2025 | Uptravi |
| Chiesi USA, INC. | $875.00 | 2025 | |
| Philips North America LLC | $870.73 | 2019-2025 | Vest Therapy Und, (Ak6) Vest Therapy |
| Ani Pharmaceuticals, INC. | $581.00 | 2022-2025 | Purified Cortrophin Gel |
| Genzyme Corporation | $561.34 | 2019-2024 | |
| Insmed, INC. | $543.91 | 2019-2025 | Arikayce, Brinsupri |
| United Therapeutics Corporation | $537.76 | 2019-2025 | Tyvaso, Orenitram, Tyvaso |
| Electromed, INC. | $466.00 | 2019-2024 | Smartvest |
| Harmony Biosciences LLC | $442.75 | 2020-2024 | Wakix |
| Regeneron Healthcare Solutions, INC. | $414.67 | 2019-2024 | Dupixent |
| Takeda Pharmaceuticals U.S.A., INC. | $371.66 | 2020-2023 | Aralast, Cuvitru |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $369.02 | 2019-2023 | |
| Stryker Corporation | $328.21 | 2022-2024 | Mako, Accolade, Triathlon |
| Grifols USA, LLC | $312.95 | 2019-2025 | Prolastin-C Liquid |
| Verona Pharma, INC. | $293.18 | 2025 | Ohtuvayre |
| Horizon Therapeutics Plc | $220.67 | 2019-2022 | |
| Shire North American Group INC | $209.84 | 2019 | |
| Axsome Therapeutics, INC. | $189.41 | 2023 | Sunosi |
| Baxter Healthcare | $174.16 | 2023-2025 | Hillrom - Life 2000 Ventilation System, Hillrom - Carnation Ambulatory Monitor, Hillrom - Vest System Model 105 Home Care |
| Mylan Specialty L.P. | $166.79 | 2019-2021 | |
| Sunovion Pharmaceuticals INC. | $152.08 | 2019-2021 | |
| Zimmer Biomet Holdings, INC. | $145.88 | 2025 | |
| Optinose US, INC. | $82.15 | 2023-2025 | |
| Inspire Medical Systems, INC. | $80.91 | 2024-2025 | Inspire |
| E.R. Squibb & Sons, L.L.C. | $59.21 | 2021 | |
| Paratek Pharmaceuticals, INC. | $56.50 | 2022-2023 | Nuzyra |
| Abbvie INC. | $54.96 | 2025 | |
| Teva Pharmaceuticals USA, INC. | $54.61 | 2019-2023 | |
| Gilead Sciences, INC. | $52.05 | 2019-2022 | |
| Amgen INC. | $46.99 | 2022-2025 | Tezspire |
| Covis Pharma Gmbh | $46.53 | 2022 | |
| Circassia INC. | $41.23 | 2019 | |
| Genentech USA, INC. | $41.18 | 2019 | |
| Nabriva Therapeutics, Plc | $29.92 | 2022 | |
| Janssen Pharmaceuticals, INC | $28.74 | 2022 | |
| Merck Sharp & Dohme LLC | $28.67 | 2021-2022 | |
| Jazz Pharmaceuticals INC. | $27.79 | 2019 | |
| Csl Behring | $16.63 | 2024 | Hizentra |
| Lilly USA, LLC | $15.49 | 2023 | Jardiance |
| Phadia US INC. | $14.69 | 2021 | |
| Mallinckrodt Enterprises LLC | $13.86 | 2019 | |
| Vertical Pharmaceuticals, LLC | $13.81 | 2019 | |
| Advanced Respiratory, INC | $11.19 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elie Mansour listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.